Taysha Gene Therapies, Inc. (TSHA) Earnings Per Share (EPS)
Taysha Gene Therapies, Inc. (TSHA) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2020-12-31 | -$3.40 |
| 2021-12-31 | -$4.64 |
| 2022-12-31 | -$3.78 |
| 2023-12-31 | -$0.96 |
| 2024-12-31 | -$0.36 |
| 2025-12-31 | -$0.34 |
How TSHA compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| TRVI | Trevi Therapeutics Inc. | -$0.32 |
| ACRS | Aclaris Therapeutics Inc. | -$0.53 |
| CRVS | Corvus Pharmaceuticals Inc. | -$0.53 |
| AVXL | Anavex Life Sciences Corp. | -$0.54 |
| ALDX | Aldeyra Therapeutics Inc. | -$0.56 |
These are five companies in the same sector as TSHA with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Taysha Gene Therapies, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("TSHA")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TSHA | $6.39 | +0.39% | 0.56M |
| 3 | ||||
| 4 | ||||
| 5 |